Postnatal corticosteroids to treat or to prevent chronic lung disease: a survey of neonatologists' practices

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 94, Issue 1, 2009, Pages

  Niwas, R ^a   Kamat, M ^a,b   Klino, P ^a   Yeh, T F ^a,c   Pyati, S ^a,b  

^a Jr Hospital of Cook County   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ASSISTED VENTILATION; CHRONIC LUNG DISEASE; CLINICAL PRACTICE; HEALTH SURVEY; HUMAN; LETTER; NEONATOLOGY; NEWBORN INTENSIVE CARE; OXYGEN SUPPLY; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; HEALTH CARE SURVEYS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LUNG DISEASES; PROFESSIONAL PRACTICE;

EID: 58349106228     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2007.136390     Document Type: Letter

References (4)

1. American Academy of Pediatrics, Committee on Fetus and Newborn and Canadian Pediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109:330-8.
2. Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004; 350:1304-13.
3. Gross SJ, Anbar RD, Mettelman BB. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics 2005; 115:681-7.
4. Doyle LW, Halliday HL, Ehrenkranz RA, et al. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 2005; 115:655-61.